CG8-33573-16312
3 vaccinations
4 coded responses
23 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 303 / GA
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Registered in v-safe
-
2021-06-15
Dose 1 — Pfizer-BioNTech
- 2021-06-15
- 2021-06-16
- 2021-06-17
- 2021-06-18
- 2021-06-19
-
2021-06-21
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-06-22
Health check-in — day 7, dose 1Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationAdult check-in
-
2021-06-22
Report sent to call center — day 7, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-06-24
-
2021-06-28
Call successfulParticipant prefers to complete VAERS report online
- 2021-07-01
-
2021-07-08
Dose 2 — Pfizer-BioNTech
- 2021-07-08
-
2021-07-09
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Poor · Site: Pain · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Runny nose and sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-10
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work or attend schoolFree text: Runny nose and sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-11
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-12
- 2021-07-13
- 2021-07-15
- 2021-07-22
- 2021-07-31
- 2021-08-05
- 2021-08-12
- 2021-08-19
- 2021-10-07
- 2022-01-08
-
2022-01-14
Dose 3 — Pfizer-BioNTech
-
2022-07-15
Survey response — 6 months, dose 3MedDRA: Cough — Feeling: Good · Be unable to work or attend schoolFree text: Very intense wet coughMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-15 | Pfizer-BioNTech | |
| 2 | 2021-07-08 | Pfizer-BioNTech | No |
| 3 | 2022-01-14 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose and sore throat
Systemic reaction (other): Runny nose and sore throat
Systemic reaction (other): Runny nose
Release 12 — 6 months, dose 3
Symptoms: Very intense wet cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release